Convalescent plasma (CP) therapy, which uses blood plasma from recovered COVID-19 patients, shows promise during small random blind study in treating the disease sciencetimes.com/articles/25236…
Coronavirus: low antibody levels raise questions about reinfection risk
Scientists in Shanghai say some recovered patients show no signs of the neutralizing proteins, could have implications for vaccine development and herd immunity scmp.com/news/china/sci…
Scientists in Shanghai say some recovered patients show no signs of the neutralizing proteins, could have implications for vaccine development and herd immunity scmp.com/news/china/sci…
Human testing beginning on second coronavirus vaccine candidate, a DNA vaccine developed by Inovio. The first vaccine to begin human trials is an mRNA vaccine developed by Moderna
thehill.com/policy/healthc…
thehill.com/policy/healthc…
Japan and Russia beginning stockpiling anti-viral drug favipiravir, originally developed by a Fujifilm subsidiary, as drug undergoes clinical trials in Japan
It has previously been found to be effective against a number of RNA viruses
newsweek.com/russia-favipir…
It has previously been found to be effective against a number of RNA viruses
newsweek.com/russia-favipir…
